Ribociclib plus Endocrine Therapy in Early Breast Cancer. Reply

N Engl J Med. 2024 Jun 20;390(23):2221-2222. doi: 10.1056/NEJMc2404917.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aminopyridines* / administration & dosage
  • Aminopyridines* / therapeutic use
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols* / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / pathology
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Purines* / administration & dosage
  • Purines* / therapeutic use

Substances

  • Aminopyridines
  • Antineoplastic Agents, Hormonal
  • Purines
  • ribociclib